SSKN

STRATA Skin Sciences, Inc.

Price Chart

Latest Quote

$0.12

-0.01 (-7.69%)

Current Price

Previous Close	$0.13
Open	$0.12
Day High	$0.12
Day Low	$0.12
Volume	6,494

Fetched: 2026-06-15T12:54:13

Stock Information

Shares Outstanding	5.89M
Total Debt	$16.27M
Cash Equivalents	$7.91M
Revenue	$30.70M
Net Income	$-6.26M
Sector	Healthcare
Industry	Medical Devices
Market Cap	$707K
EPS (TTM)	$-1.35
Exchange	PNK

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Enterprise Value	$9.07M
Sales	$30.70M
Income	$-6.26M
Book/sh	$0.49
Cash/sh	$1.34
Employees	114

Financial Ratios

Quick Ratio	0.45
Current Ratio	0.58
Debt/Eq	559.42

Returns & Margins

ROA	-11.14%
ROE	-158.91%
Gross Margin	58.25%
Operating Margin	0.40%
Profit Margin	-20.40%

Ownership

Insider Ownership	9.97%
Institutional Ownership	25.38%
Insider & Institutional transactions data not available

Valuation Ratios

Forward P/E	-0.09
PEG	0.03
P/S	0.02
P/B	0.24

Analyst Data

Recommendation

none

Technical Indicators

SMA20	$0.13
SMA50	$0.14
SMA200	$0.98
RSI	36.36
ATR	0.0243

Shares Float	4.20M
Short Float	8.13%
Short Ratio	5.32
Volatility	-0.08
Rel Volume	0.48

Performance History

Week	-20.00%
Month	-25.00%
Quarter	-53.85%
6 Months	-91.61%
YTD	-90.55%
Year	-94.85%
3 Years	-98.65%
5 Years	-99.18%
10 Years	-99.67%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-06-12	$0.12	10,700
2026-06-11	$0.13	0
2026-06-10	$0.13	1,100
2026-06-09	$0.12	3,100
2026-06-08	$0.13	23,600
2026-06-05	$0.15	6,700
2026-06-04	$0.15	88,600
2026-06-03	$0.12	300
2026-06-02	$0.13	8,300
2026-06-01	$0.13	17,400
2026-05-29	$0.13	74,900
2026-05-28	$0.13	47,200
2026-05-27	$0.14	28,800
2026-05-26	$0.15	3,800
2026-05-22	$0.15	87,500
2026-05-21	$0.15	13,200
2026-05-20	$0.13	7,000
2026-05-19	$0.16	10,500
2026-05-18	$0.12	400
2026-05-15	$0.12	14,000
2026-05-14	$0.13	1,300
2026-05-13	$0.16	1,600

About STRATA Skin Sciences, Inc.

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc. and changed its name to STRATA Skin Sciences, Inc. in December 2015. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.

📰 Latest News

SSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's Efficacy

Zacks • 2026-02-18T14:51:00Z

Strata Skin Sciences Inc (SSKN) Q3 2025 Earnings Call Highlights: Navigating Challenges and ...

GuruFocus.com • 2025-11-17T03:00:59Z

STRATA Skin (SSKN) Earnings Call Transcript

Motley Fool • 2025-11-13T22:42:20Z

Google Gets Reprieve in Antitrust Case as US Equity Futures Turn Mixed Pre-Bell

MT Newswires • 2025-09-03T13:08:07Z

Analysts Just Made A Major Revision To Their STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Revenue Forecasts

Simply Wall St. • 2025-08-16T12:17:42Z

STRATA Skin Sciences Second Quarter 2025 Earnings: Misses Expectations

Simply Wall St. • 2025-08-15T10:39:47Z

Period:

Income Statement (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue
Reconciled Cost Of Revenue	$14,481,000	$14,897,000	$14,393,000	$10,127,000
Cost Of Revenue	$14,481,000	$14,897,000	$14,393,000	$10,127,000
Total Revenue	$33,562,000	$33,358,000	$36,161,000	$29,977,000
Operating Revenue	$33,562,000	$33,358,000	$36,161,000	$29,977,000
Expenses
Interest Expense	$2,107,000	$1,640,000	$926,000	$314,000
Total Expenses	$38,956,000	$39,678,000	$40,810,000	$34,379,000
Other Income Expense	$-2,997,000	$-3,193,000	-	$2,029,000
Other Non Operating Income Expenses	$864,000	-	-	-
Net Non Operating Interest Income Expense	$-1,865,000	$-1,409,000	$-837,000	$-299,000
Interest Expense Non Operating	$2,107,000	$1,640,000	$926,000	$314,000
Operating Expense	$24,475,000	$24,781,000	$26,417,000	$24,252,000
Selling And Marketing Expense	$12,289,000	$12,956,000	$15,301,000	$13,106,000
General And Administrative Expense	$11,303,000	$10,508,000	$10,087,000	$9,712,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-10,086,000	$-10,830,000	$-5,549,000	$-2,706,000
Net Interest Income	$-1,865,000	$-1,409,000	$-837,000	$-299,000
Interest Income	$242,000	$231,000	$89,000	$15,000
Normalized Income	$-6,289,093	$-7,663,896	$-5,549,000	$-4,187,170
Net Income From Continuing And Discontinued Operation	$-10,086,000	$-10,830,000	$-5,549,000	$-2,706,000
Total Operating Income As Reported	$-9,255,000	$-8,604,000	$-4,649,000	$-4,402,000
Net Income Common Stockholders	$-10,086,000	$-10,830,000	$-5,549,000	$-2,706,000
Net Income	$-10,086,000	$-10,830,000	$-5,549,000	$-2,706,000
Net Income Including Noncontrolling Interests	$-10,086,000	$-10,830,000	$-5,549,000	$-2,706,000
Net Income Continuous Operations	$-10,086,000	$-10,830,000	$-5,549,000	$-2,706,000
Pretax Income	$-10,256,000	$-10,922,000	$-5,486,000	$-2,672,000
Special Income Charges	$-3,861,000	$-3,193,000	$0	$2,029,000
Interest Income Non Operating	$242,000	$231,000	$89,000	$15,000
Operating Income	$-5,394,000	$-6,320,000	$-4,649,000	$-4,402,000
Gross Profit	$19,081,000	$18,461,000	$21,768,000	$19,850,000
Per Share
Diluted EPS	$-2.65	$-3.10	$-1.60	$-0.80
Basic EPS	$-2.65	$-3.10	$-1.60	$-0.80
Other
Tax Effect Of Unusual Items	$-64,093	$-26,896	$0	$547,830
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$1,019,000	$-187,000	$1,128,000	$-301,000
Total Unusual Items	$-3,861,000	$-3,193,000	$0	$2,029,000
Total Unusual Items Excluding Goodwill	$-3,861,000	$-3,193,000	$0	$2,029,000
Reconciled Depreciation	$5,307,000	$5,902,000	$5,688,000	$4,086,000
EBITDA (Bullshit earnings)	$-2,842,000	$-3,380,000	$1,128,000	$1,728,000
EBIT	$-8,149,000	$-9,282,000	$-4,560,000	$-2,358,000
Diluted Average Shares	$3,807,186	$3,492,029	$3,471,224	$3,405,027
Basic Average Shares	$3,807,186	$3,492,029	$3,471,224	$3,405,027
Diluted NI Availto Com Stockholders	$-10,086,000	$-10,830,000	$-5,549,000	$-2,706,000
Tax Provision	$-170,000	$-92,000	$63,000	$34,000
Impairment Of Capital Assets	$3,861,000	$2,284,000	$0	-
Research And Development	$883,000	$1,317,000	$1,029,000	$1,434,000
Selling General And Administration	$23,592,000	$23,464,000	$25,388,000	$22,818,000
Other Gand A	$11,303,000	$10,508,000	$10,087,000	$9,712,000
Other Special Charges	-	$909,000	-	$-2,029,000

Fetched: 2026-02-19

Balance Sheet (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Net Tangible Assets	$-3,034,000	$-1,150,000	$-4,366,000	$6,528,000
Total Assets	$36,157,000	$42,016,000	$52,272,000	$46,593,000
Total Non Current Assets	$19,562,000	$26,473,000	$37,220,000	$26,623,000
Other Non Current Assets	$231,000	$231,000	$98,000	$216,000
Goodwill And Other Intangible Assets	$8,006,000	$13,838,000	$26,197,000	$18,886,000
Other Intangible Assets	$5,348,000	$7,319,000	$17,394,000	$10,083,000
Current Assets	$16,595,000	$15,543,000	$15,052,000	$19,970,000
Other Current Assets	$501,000	$312,000	$691,000	$462,000
Restricted Cash	$1,334,000	$1,334,000	$1,361,000	$0
Inventory	$2,246,000	$2,673,000	$3,095,000	$3,489,000
Receivables	$5,253,000	$4,440,000	$4,471,000	$3,433,000
Accounts Receivable	$5,253,000	$4,440,000	$4,471,000	$3,433,000
Allowance For Doubtful Accounts Receivable	$-433,000	$-222,000	$-222,000	$-275,000
Gross Accounts Receivable	$5,686,000	$4,662,000	$4,693,000	$3,708,000
Cash Cash Equivalents And Short Term Investments	$7,261,000	$6,784,000	$5,434,000	$12,586,000
Cash And Cash Equivalents	$7,261,000	$6,784,000	$5,434,000	$12,586,000
Prepaid Assets	-	-	-	$462,000
Debt
Net Debt	$7,931,000	$8,260,000	$2,042,000	-
Total Debt	$16,439,000	$15,633,000	$8,441,000	$8,029,000
Long Term Debt And Capital Lease Obligation	$16,111,000	$15,281,000	$8,086,000	$7,711,000
Long Term Debt	$15,192,000	$15,044,000	$7,476,000	$7,319,000
Current Debt And Capital Lease Obligation	$328,000	$352,000	$355,000	$318,000
Liabilities
Total Liabilities Net Minority Interest	$31,185,000	$29,328,000	$30,441,000	$21,179,000
Total Non Current Liabilities Net Minority Interest	$16,560,000	$17,154,000	$17,015,000	$8,377,000
Other Non Current Liabilities	$449,000	$1,687,000	$8,623,000	$400,000
Non Current Deferred Liabilities	$0	$186,000	$306,000	$266,000
Non Current Deferred Taxes Liabilities	$0	$186,000	$306,000	$266,000
Current Liabilities	$14,625,000	$12,174,000	$13,426,000	$12,802,000
Other Current Liabilities	$1,030,000	$53,000	$313,000	-
Current Deferred Liabilities	$2,241,000	$2,120,000	$2,778,000	$3,285,000
Payables And Accrued Expenses	$9,245,000	$7,970,000	$7,983,000	$7,147,000
Payables	$8,804,000	$7,659,000	$7,411,000	$6,519,000
Total Tax Payable	$6,371,000	$4,316,000	$3,986,000	$3,697,000
Accounts Payable	$2,433,000	$3,343,000	$3,425,000	$2,822,000
Current Notes Payable	-	-	-	$0
Equity
Common Stock Equity	$4,972,000	$12,688,000	$21,831,000	$25,414,000
Total Equity Gross Minority Interest	$4,972,000	$12,688,000	$21,831,000	$25,414,000
Stockholders Equity	$4,972,000	$12,688,000	$21,831,000	$25,414,000
Retained Earnings	$-248,144,000	$-238,058,000	$-227,228,000	$-221,679,000
Other
Ordinary Shares Number	$4,171,161	$3,506,092	$3,472,304	$3,436,467
Share Issued	$4,171,161	$3,506,092	$3,472,304	$3,436,467
Tangible Book Value	$-3,034,000	$-1,150,000	$-4,366,000	$6,528,000
Invested Capital	$20,164,000	$27,732,000	$29,307,000	$32,733,000
Working Capital	$1,970,000	$3,369,000	$1,626,000	$7,168,000
Capital Lease Obligations	$1,247,000	$589,000	$965,000	$710,000
Total Capitalization	$20,164,000	$27,732,000	$29,307,000	$32,733,000
Additional Paid In Capital	$253,112,000	$250,742,000	$249,024,000	$247,059,000
Capital Stock	$4,000	$4,000	$35,000	$34,000
Common Stock	$4,000	$4,000	$35,000	$34,000
Preferred Stock	$0	$0	$0	$0
Long Term Capital Lease Obligation	$919,000	$237,000	$610,000	$392,000
Current Deferred Revenue	$2,241,000	$2,120,000	$2,778,000	$3,285,000
Current Capital Lease Obligation	$328,000	$352,000	$355,000	$318,000
Pensionand Other Post Retirement Benefit Plans Current	$1,781,000	$1,679,000	$1,997,000	$2,052,000
Current Accrued Expenses	$441,000	$311,000	$572,000	$628,000
Goodwill	$2,658,000	$6,519,000	$8,803,000	$8,803,000
Net PPE	$11,325,000	$12,404,000	$10,925,000	$7,521,000
Accumulated Depreciation	$-26,148,000	$-24,284,000	$-21,956,000	$-19,771,000
Gross PPE	$37,473,000	$36,688,000	$32,881,000	$27,292,000
Leases	$87,000	$203,000	$136,000	$254,000
Construction In Progress	$2,093,000	$3,231,000	$2,452,000	-
Other Properties	$34,753,000	$32,721,000	$29,765,000	$26,587,000
Machinery Furniture Equipment	$540,000	$533,000	$528,000	$451,000
Properties	$0	$0	$0	$0
Finished Goods	$205,000	$481,000	$129,000	$288,000
Raw Materials	$2,041,000	$2,192,000	$2,966,000	$3,201,000
Treasury Shares Number	-	$0	-	-
Current Provisions	-	$180,000	$136,000	$59,000
Non Current Deferred Revenue	-	-	$314,000	$400,000

Fetched: 2026-02-19

Cash Flow Statement (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow
Free Cash Flow	$-1,448,000	$-5,538,000	$-4,660,000	$-2,145,000
Operating Activities
Operating Cash Flow	$188,000	$-519,000	$-924,000	$1,508,000
Cash Flow From Continuing Operating Activities	$188,000	$-519,000	$-924,000	$1,508,000
Operating Gains Losses	$49,000	$981,000	$52,000	$-1,889,000
Investing Activities
Capital Expenditure	$-1,636,000	$-5,019,000	$-3,736,000	$-3,653,000
Investing Cash Flow	$-1,636,000	$-5,019,000	$-4,367,000	$-7,126,000
Cash Flow From Continuing Investing Activities	$-1,636,000	$-5,019,000	$-4,367,000	$-7,126,000
Net Other Investing Changes	-	-	$-631,000	$-3,473,000
Financing Activities
Issuance Of Capital Stock	$1,943,000	$0	-	-
Financing Cash Flow	$1,925,000	$6,861,000	$-500,000	$92,000
Cash Flow From Continuing Financing Activities	$1,925,000	$6,861,000	$-500,000	$92,000
Net Other Financing Charges	$-18,000	$-139,000	$-500,000	$-133,000
Net Common Stock Issuance	$1,943,000	$0	-	-
Common Stock Issuance	$1,943,000	$0	-	-
Other
Issuance Of Debt	$0	$7,000,000	$0	$8,000,000
Interest Paid Supplemental Data	$1,973,000	$1,415,000	$744,000	$222,000
Income Tax Paid Supplemental Data	$23,000	$22,000	$19,000	$0
End Cash Position	$8,595,000	$8,118,000	$6,795,000	$12,586,000
Beginning Cash Position	$8,118,000	$6,795,000	$12,586,000	$18,112,000
Changes In Cash	$477,000	$1,323,000	$-5,791,000	$-5,526,000
Net Issuance Payments Of Debt	$0	$7,000,000	$0	$225,000
Net Long Term Debt Issuance	$0	$7,000,000	$0	$225,000
Long Term Debt Issuance	$0	$7,000,000	$0	$8,000,000
Net PPE Purchase And Sale	$-1,636,000	$-5,019,000	$-3,736,000	$-3,653,000
Purchase Of PPE	$-1,636,000	$-5,019,000	$-3,736,000	$-3,653,000
Change In Working Capital	$688,000	$-69,000	$-2,885,000	$324,000
Change In Other Working Capital	$-57,000	$-472,000	$-644,000	$-444,000
Change In Other Current Liabilities	$-319,000	$-376,000	$-477,000	$-369,000
Change In Payables And Accrued Expense	$1,312,000	$-297,000	$832,000	$1,737,000
Change In Accrued Expense	$2,266,000	$-197,000	$229,000	$1,679,000
Change In Payable	$-954,000	$-100,000	$603,000	$58,000
Change In Account Payable	$-954,000	$-100,000	$603,000	$58,000
Change In Prepaid Assets	$-189,000	$246,000	$-111,000	$-65,000
Change In Inventory	$572,000	$689,000	$-1,340,000	$-45,000
Change In Receivables	$-631,000	$141,000	$-1,145,000	$-490,000
Changes In Account Receivables	$-631,000	$141,000	$-1,145,000	$-490,000
Other Non Cash Items	$148,000	$140,000	$157,000	$37,000
Stock Based Compensation	$427,000	$1,303,000	$1,466,000	$1,643,000
Provisionand Write Offof Assets	$-182,000	$-110,000	$107,000	$1,000
Asset Impairment Charge	$4,023,000	$2,284,000	$0	-
Deferred Tax	$-186,000	$-120,000	$40,000	$12,000
Deferred Income Tax	$-186,000	$-120,000	$40,000	$12,000
Depreciation Amortization Depletion	$5,307,000	$5,902,000	$5,688,000	$4,086,000
Depreciation And Amortization	$5,307,000	$5,902,000	$5,688,000	$4,086,000
Depreciation	$5,307,000	$5,902,000	$5,688,000	$4,086,000
Gain Loss On Sale Of PPE	$49,000	$72,000	$52,000	$140,000
Net Income From Continuing Operations	$-10,086,000	$-10,830,000	$-5,549,000	$-2,706,000
Repayment Of Debt	-	-	$0	$-7,775,000
Long Term Debt Payments	-	-	$0	$-7,775,000
Proceeds From Stock Option Exercised	-	-	-	$0
Net Business Purchase And Sale	-	-	-	$-3,473,000
Purchase Of Business	-	-	-	$-3,473,000

Fetched: 2026-02-19